Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
cytokine induced killer cells (1 trial)
cd19 car-t cells (1 trial)
Colonic Neoplasms (Phase 2)
Leukemia (Phase 1)
Leukemia, Lymphoid (Phase 1)
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 1)
Trials (2 total)
Trial APIs (2 total)